BAX and colorectal cancer: Research by Lin et al. demonstrated that EESB reduces the expression of CyclinD1, Bcl-2, and ATP binding cassette subfamily G member 2 (ABCG2), while upregulating p21 and Bax expression in HCT-8/5-FU colorectal cancer cells.